INTRODUCTIONThe safety and short‐term benefits of laparoscopic surgery for rectal cancer when compared to open surgery has been demonstrated in many randomized controlled trials. The long‐term results of some of these trials were published recently which showed similar oncological outcomes between the laparoscopic and open arms. Neoadjuvant chemoradiation (NCRT) is recommended for most patients with locally advanced mid and lower third rectal cancers since it has better local control and a superior toxicity profile when compared to adjuvant chemoradiation. Only one randomized trial till date, the Comparison of Open versus laparoscopic surgery for mid or low REctal cancer After Neoadjuvant chemoradiotherapy (COREAN) trial has shown that laparoscopic surgery has similar disease‐free survival (DFS) when compared to open surgery in patients who have received NCRT.However, the primary end‐points in this trial as in the others that reported on oncological outcomes were the 3‐year DFS or local recurrence rates. It is now known that following NCRT local recurrence may be delayed, with nearly a quarter of them occurring beyond 5 years. Therefore, it has been suggested that patients who receive NCRT need to have a long‐term follow‐up beyond 5 years to assess the treatment effects, especially on local control. Hence, the
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera